IC-202-A
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-03591 |
| CAS | |
| Molecular Weight | 572.74 |
| Molecular Formula | C27H52N6O7 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
IC-202-A shows immunosuppressive activity, with IC50 of 3.6 μg/mL as determined by MLCR, and has a strong inhibitory effect on Blastogensis induced by ConA or lipopolysaccharide (LPS).
- Specification
- Properties
- Price Product List
| IUPAC Name | N-[5-[[4-[5-[[4-[5-aminopentyl(hydroxy)amino]-4-oxobutanoyl]amino]pentyl-hydroxyamino]-4-oxobutanoyl]amino]pentyl]butan-1-imine oxide |
| Canonical SMILES | CCCC=[N+](CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)[O-] |
| InChI | InChI=1S/C27H52N6O7/c1-2-3-20-31(38)21-10-5-8-18-29-24(34)14-16-27(37)33(40)23-12-6-9-19-30-25(35)13-15-26(36)32(39)22-11-4-7-17-28/h20,39-40H,2-19,21-23,28H2,1H3,(H,29,34)(H,30,35)/b31-20- |
| InChI Key | ANTPZYRJTJVDSW-GTWSWNCMSA-N |
| Appearance | Hygroscopic Powder |
| Density | 1.1±0.1 g/cm3 |
| BBF-02577 | Pneumocandin C0 | Inquiry |
| BBF-03862 | Cefozopran hydrochloride | Inquiry |
| BBF-03963 | Pristinamycin | Inquiry |
| BBF-03794 | Geneticin sulfate | Inquiry |
| BBF-03781 | Resveratrol | Inquiry |
| BBF-03904 | Nosiheptide | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
